General Information

Name:
Chris Ahlstrand
Fool Since:
February 28 2011
Where I Live:
Chatham, NJ
Where I Grew Up:
Boulder, CO
Gender:
Male

Investing Basics

Investing Experience:
High
Risk Tolerance:
High
Investing Style:
Trader
Portfolio Size:
Large (12 or more Stocks)
Types of Investments:
Stocks and ETFs.
Stocks I Own:
VRTX, VO, PGF, VWO, VIG, VNQ, IPHYF, VGK, CNAT, EOG, XNCR, ALKS, JCI, ACRX, JCI, JNK, OMER, PANW, GILD, GOOG, RSP, DVN, LQD, WY, VPL, MRK, NPSP, BMY, LNG, RWX, VSS, CI, ACHN, MPSYF, EPI, PCL, OPHT, ITMN, XNCR, CNAT, RSX, POZN, ALDR, Long January 2015 90 Calls on VRTX, Long January 2015 50 Calls on BMRN, Long July 2014 70 Calls on VRTX, Short July 2014 80 Calls on VRTX, Long January 2015 50 Calls on GILD, Long January 2016 35 Calls on EEM, Long January 2015 50 Calls on ABBV, Short June 2014 10 Puts on TKMR,

Investing Favorites

Industries:
Biotech
Blogs:
ahlstrac.wordpress.com

Investing Expertise

My Area of Expertise:
Biotech
Greatest Investment:
Buying calls in BMY just prior to nivolumab data was released. Made 1,000% in less than a week.
Worst Investment:
Any one of my numerous options investments that I had a 100% loss in
Money I Manage:
Just my own

Education And Work Information

School(s) Attended
University of Colorado
Job Title
Freelance writer
Company / Organization
Motley Fool
Former Jobs
Hedgefund.net, Dealogic

How I Invest

I have a diversified portfolio of low cost index ETFs that make up approximately 50% of my portfolio, and invest the other 50% in individual companies based on momentum, catalysts or valuation. A significant portion of my portfolio is in biotech and pharma, and many of my positions are initiated based solely on a capturing return generated by a catalyst or event, generally from data on clinical trials or FDA approval decisions. I often use options in these situations. I prefer to hold stocks for a longer term but won't hesitate to trade in and out of positions and take profits or realize losses quickly.